GET THE APP

Towards a Dengue-free Future: Advances in Vaccines, Mosquito Control and Research
..

Virology: Current Research

ISSN: 2736-657X

Open Access

Mini Review - (2024) Volume 8, Issue 3

Towards a Dengue-free Future: Advances in Vaccines, Mosquito Control and Research

Mashooma Sayed Qureshi*
*Correspondence: Mashooma Sayed Qureshi, Department of Virology, University of Dhaka, Dhaka, Bangladesh, Email:
Department of Virology, University of Dhaka, Dhaka, Bangladesh

Received: 01-May-2024, Manuscript No. vcrh-24-138365; Editor assigned: 03-May-2024, Pre QC No. P-138365; Reviewed: 15-May-2024, QC No. Q-138365; Revised: 22-May-2024, Manuscript No. R-138365; Published: 29-May-2024 , DOI: 10.37421/2736-657X.2024.8.246
Citation: Qureshi, Mashooma Sayed. “Towards a Dengue-free Future: Advances in Vaccines, Mosquito Control and Research.” Virol Curr Res 8 (2024): 246.
Copyright: © 2024 Qureshi MS. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Dengue poses a significant global health threat, especially in tropical and subtropical regions. Over time, scientists and innovators have been actively engaged in addressing various aspects of dengue prevention, diagnosis, and treatment. The development of an effective dengue vaccine has been a primary focus of research efforts. Multiple vaccine candidates have been under development, targeting immunity against all four serotypes of the dengue virus. Innovations in controlling the Aedes aegypti mosquito, responsible for transmitting dengue, have included the utilization of genetically modified mosquitoes, novel insecticides, and community-driven approaches aimed at reducing mosquito breeding sites.

Keywords

Dengue • Vaccine • Mosquito control

Introduction

Rapid and accurate diagnostic tools are crucial for timely intervention. Researchers have been working on innovative diagnostic techniques, such as point-of-care tests and advanced laboratory methods for early and accurate detection of dengue virus infections. Efforts have been made to develop specific antiviral drugs and therapies for managing dengue infections. Additionally, research is ongoing to understand the pathogenesis of severe dengue and develop effective treatments for severe cases, Innovative public health strategies have focused on community engagement, education, and awareness campaigns to promote preventive measures, such as reducing mosquito breeding sites and minimizing exposure to mosquito bites. Utilizing big data and predictive analytics has helped in forecasting dengue outbreaks, enabling early preparedness and response measures. This has facilitated more effective resource allocation and deployment of healthcare services in at-risk areas [1].

Literature Review

The urgent need for effective preventive measures, early detection, and appropriate management of dengue cases, especially in regions with high endemicity. The growing burden of the disease, both in terms of health impact and economic costs, underscores the importance of prioritizing research and interventions aimed at controlling and reducing the transmission of the dengue virus. Efforts to address the challenges posed by dengue fever should be comprehensive, encompassing various aspects such as vector control, community engagement, healthcare infrastructure improvement, and research into effective treatments and vaccines. By focusing on these areas, it is possible to alleviate the health, social, and economic burdens associated with dengue, leading to improved public health outcomes in affected regions. Their illustrative casings don't have all the earmarks of being in an end-systolic stage. Given the 3-layered incitation of the ventricle during systole, which incorporates twist, it is normal that aortoventricular point estimations might be reliant upon the time inside the cardiovascular cycle [2-4].

Various international collaborations and partnerships between research institutions, governments, and non-governmental organizations have contributed to the sharing of knowledge, resources, and expertise, accelerating dengue research and innovation globally. Strict statistical assumptions about the properties of TDP often limit the capabilities of classical forecasting methods. Intensifying efforts to control mosquito populations, such as through targeted insecticide use, community-based initiatives to eliminate breeding sites, and the use of biological control methods. Implementing comprehensive educational campaigns to raise awareness about the prevention and symptoms of dengue fever, encouraging communities to actively participate in controlling the spread of the disease. Strengthening healthcare systems, particularly in regions heavily affected by dengue, by ensuring adequate medical supplies, trained healthcare professionals, and accessible treatment facilities. Supporting research initiatives and collaborations to expedite the development and distribution of effective dengue vaccines to protect vulnerable populations [5].

Discussion

Dengue viruses are transmitted by mosquitoes of the genus Aedes, subgenus Stegomyia. The principal vector, Aedes Stegomyia aegypti, is now well established in much of the tropical and subtropical world, particularly in urban areas. It is a domestic species, highly susceptible to dengue virus infection, feeding preferentially on human blood during the daytime often taking multiple blood meals during a single geostrophic cycle. For instance, early reports of indicative execution of virtually all imaging techniques for coronary corridor illness assessment revealed especially high precision that decremented after some time. How could clinicians (and diary editors) digest these dissonant messages? Would it be advisable for one be worried about the wellbeing of oneself extending prosthesis in view of the significant information of the other hand be consoled by the complex bigger dataset? Instead of rushing to make a judgment call that this finding is unvaryingly valid or false, the actual examinations ought to be inspected for significant subtleties that might have delivered dissonant outcomes from comparative picture logical approaches [6].

Conclusion

The Authority for Working Conditions (ACT) has a publication with practical guidelines as an example that clarifies and specifies a set of situations that may be considered as a reference for the ACT's action, based on the United Kingdom law “Reporting of Injuries, Diseases, and Dangerous Occurrences Regulations” because the legislation in Portugal does not have a typification for serious accidents. By addressing these aspects and implementing comprehensive strategies, it is possible to mitigate the impact of dengue fever, reduce the number of infections, and ultimately save lives. It is crucial for stakeholders to prioritize these efforts to effectively combat the global threat posed by dengue fever. When a worker or self-employed worker who works in other people's facilities suffers a serious physical injury that necessitates specialized medical treatment, it is established that an occupational accident indicates a particularly serious situation.

Acknowledgement

None.

Conflict of Interest

None.

References

  1. Matlin, Stephen A. and Gill MR Samuels. "The global health research and innovation system (GHRIS)." The Lancet 374 (2009): 1662-1663.

    Google Scholar, Crossref, Indexed at

  2. Aburas, Hani M. "ABURAS index: A statistically developed index for dengue-transmitting vector population prediction." Int J Biol Biomed Eng 1 (2007): 47-50.

    Google Scholar, Indexed at

  3. Wilder-Smith, Annelies, Karl-Erik Renhorn, Hasitha Tissera and Sazaly Abu Bakar, et al. "DengueTools: innovative tools and strategies for the surveillance and control of dengue." Glob Health Action 5 (2012): 17273.

    Google Scholar, Crossref, Indexed at

  4. Nega, Jemberu, Solomon Taye, Yihenew Million and Chaturaka Rodrigo. "Antiretroviral treatment failure and associated factors among HIV patients on first-line antiretroviral treatment in Sekota, Northeast Ethiopia." AIDS Res Ther 17 (2020): 1-9.

    Google Scholar, Crossref, Indexed at

  5. Srisawat, Nattachai, Duane J. Gubler, Tikki Pangestu and Usa Thisyakorn, et al. "Proceedings of the 5th Asia Dengue Summit." ADVA (2023): 231.

    Google Scholar, Crossref, Indexed at

  6. Saag, Michael S., Rajesh T. Gandhi, Jennifer F. Hoy and Raphael J. Landovitz, et al. "Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society–USA panel." JAMA 324 (2020): 1651-1669.

    Google Scholar, Crossref, Indexed at

arrow_upward arrow_upward